Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease

Details for Australian Patent Application No. 2008312406 (hide)

Owner Ares Trading S.A. ZymoGenetics, Inc.

Inventors Broly, Herve; Peano, Sergio; Graffner, Hans Otto Lennart; Ponce Jr., Raphael A.

Agent Spruson & Ferguson

Pub. Number AU-A-2008312406

PCT Pub. Number WO2009/052293

Priority 60/980,331 16.10.07 US

Filing date 16 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 (2006.01) Hybrid peptides

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/052293 Priority application(s): WO2009/052293

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312409-Fraud prevention based on risk assessment rule

2008312405-Hemi-prosthesis